A flurry of bills to reform the Medicare Physician Fee Schedule (PFS) faces the lame duck Congress. Our Health Care Group investigates how those reforms could take shape and which, if any, could find their way through the...more
The decreasing value of Medicare reimbursements for physicians has caught the attention of a group of doctors in Congress. Our Heath Care Group explains how draft legislation would stabilize the Physician Fee Schedule (PFS)...more
Our Health Care Team eyes the abrupt end of payments to health care providers under the Provider Relief Fund. HRSA will no longer process or complete reconsideration requests....more
Our Health Care Group analyzes why the Health Resources & Services Administration (HRSA) is flexing its auditing muscles and explores the implications for entities that received Provider Relief Funds and American Rescue Plan...more
On June 30, 2021, the Health Resources and Services Administration (HRSA) opened the Provider Relief Fund (PRF) Reporting Portal, which providers who received PRF distributions will need to use to submit required information....more
Medicare providers face a nearly 10% reimbursement cut in 2022. Our Health Care Legislative & Public Policy Team does the math and explains how a combination of sequester cuts and expiring reimbursement support could bring a...more
As the hospital price transparency rule effective date approaches, the Administration has finalized new price transparency requirements for health plans and insurance issuers, as well as a requirement for COVID-19 test...more
Our Health Care Group reviews the nuances for eligibility and applying for the latest round of COVID-19 relief from the CARES Act’s Provider Relief Fund....more
Our Health Care Group explains new rules (final and proposed) from the Centers for Medicare & Medicaid Services on pricing transparency for hospitals and cost-sharing information for health plans....more
Despite partisan rancor in Congress over health care, one thing both parties agree on is that patients should not be surprised by an out-of-network health care bill. Our Employee Benefits & Executive Compensation and Health...more
Though the biosimilars market has evolved, and more companies are seizing the opportunities, reimbursement regulations have been unclear at best. Our Health Care Group untangles the latest rules from the Centers for Medicare...more